Cargando…

1824. Care Transformation in Infectious Diseases: Using a Novel Approach for Tracking Antimicrobial Stewardship Metrics

BACKGROUND: A key component of antimicrobial stewardship (AS) programs is the use of adequate metrics to monitor antimicrobial utilization. Limitations have been described in the literature for traditional metrics such as Defined Daily Doses (DDD) and Days of Therapy (DOT), including practitioner’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Minor, Sarah, Burns, Jordan, Herrera, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252896/
http://dx.doi.org/10.1093/ofid/ofy210.1480
_version_ 1783373370788675584
author Minor, Sarah
Burns, Jordan
Herrera, Victor
author_facet Minor, Sarah
Burns, Jordan
Herrera, Victor
author_sort Minor, Sarah
collection PubMed
description BACKGROUND: A key component of antimicrobial stewardship (AS) programs is the use of adequate metrics to monitor antimicrobial utilization. Limitations have been described in the literature for traditional metrics such as Defined Daily Doses (DDD) and Days of Therapy (DOT), including practitioner’s unfamiliarity with the terminology in relation to their meaning. This abstract describes an innovative approach developed by our organization that resulted in improved utilization of high-cost antimicrobials and increased the engagement of practitioners based on real-time (RT) analytics using a novel metric: Defined Daily Goal (DDG). METHODS: A RT medication utilization dashboard (DB) for daptomycin (DAP) was created in October 2017 by clinical analysts and pharmacists. The DB provides a list of patients with active orders for DAP and compares the sum of active orders to the sum of available orders to meet the DDG. At Florida Hospital Orlando (FHO), the DAP goal based on national benchmark data were 6.8 days of therapy (DOT)/1,000 patient days (PDs) or a total of 240 orders/month. The average PDs/month was calculated to be 35, 380, thus the DAP DDG for FHO was determined to be 8 orders/day to meet a goal of 6.8 DOT/month. This goal of 8 DAP orders/day was built into the DB for daily AS team review. This calculation allowed for a conversion of our monthly DOT goal to a DDG equivalent. RESULTS: From October to December 2017, the DB identified an average of 230.7 orders/month at FHO, which was below the goal of 240 orders/month. Visualizing the daily goals for the number of allotted orders for DAP using a DDG format, this allowed the AS team to effectively meet the DOT/1,000 PDs goal. Focusing on the DDG combined with standard AS activities, resulted in a significant reduction of DAP utilization. When discussing utilization goals with ID specialists and general practitioners, the use of the DDG concept proved to be intuitive and facilitated understanding around specific metrics. CONCLUSION: Implementation of a medication utilization RT DB, combined with the introduction of the DDG concept, allowed for an actionable measure to trend daily and facilitated the goals of our AS program. Based on this valuable information provided by the DB, this intiative has now been expanded to include other high-cost agents across all campuses. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6252896
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62528962018-11-28 1824. Care Transformation in Infectious Diseases: Using a Novel Approach for Tracking Antimicrobial Stewardship Metrics Minor, Sarah Burns, Jordan Herrera, Victor Open Forum Infect Dis Abstracts BACKGROUND: A key component of antimicrobial stewardship (AS) programs is the use of adequate metrics to monitor antimicrobial utilization. Limitations have been described in the literature for traditional metrics such as Defined Daily Doses (DDD) and Days of Therapy (DOT), including practitioner’s unfamiliarity with the terminology in relation to their meaning. This abstract describes an innovative approach developed by our organization that resulted in improved utilization of high-cost antimicrobials and increased the engagement of practitioners based on real-time (RT) analytics using a novel metric: Defined Daily Goal (DDG). METHODS: A RT medication utilization dashboard (DB) for daptomycin (DAP) was created in October 2017 by clinical analysts and pharmacists. The DB provides a list of patients with active orders for DAP and compares the sum of active orders to the sum of available orders to meet the DDG. At Florida Hospital Orlando (FHO), the DAP goal based on national benchmark data were 6.8 days of therapy (DOT)/1,000 patient days (PDs) or a total of 240 orders/month. The average PDs/month was calculated to be 35, 380, thus the DAP DDG for FHO was determined to be 8 orders/day to meet a goal of 6.8 DOT/month. This goal of 8 DAP orders/day was built into the DB for daily AS team review. This calculation allowed for a conversion of our monthly DOT goal to a DDG equivalent. RESULTS: From October to December 2017, the DB identified an average of 230.7 orders/month at FHO, which was below the goal of 240 orders/month. Visualizing the daily goals for the number of allotted orders for DAP using a DDG format, this allowed the AS team to effectively meet the DOT/1,000 PDs goal. Focusing on the DDG combined with standard AS activities, resulted in a significant reduction of DAP utilization. When discussing utilization goals with ID specialists and general practitioners, the use of the DDG concept proved to be intuitive and facilitated understanding around specific metrics. CONCLUSION: Implementation of a medication utilization RT DB, combined with the introduction of the DDG concept, allowed for an actionable measure to trend daily and facilitated the goals of our AS program. Based on this valuable information provided by the DB, this intiative has now been expanded to include other high-cost agents across all campuses. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6252896/ http://dx.doi.org/10.1093/ofid/ofy210.1480 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Minor, Sarah
Burns, Jordan
Herrera, Victor
1824. Care Transformation in Infectious Diseases: Using a Novel Approach for Tracking Antimicrobial Stewardship Metrics
title 1824. Care Transformation in Infectious Diseases: Using a Novel Approach for Tracking Antimicrobial Stewardship Metrics
title_full 1824. Care Transformation in Infectious Diseases: Using a Novel Approach for Tracking Antimicrobial Stewardship Metrics
title_fullStr 1824. Care Transformation in Infectious Diseases: Using a Novel Approach for Tracking Antimicrobial Stewardship Metrics
title_full_unstemmed 1824. Care Transformation in Infectious Diseases: Using a Novel Approach for Tracking Antimicrobial Stewardship Metrics
title_short 1824. Care Transformation in Infectious Diseases: Using a Novel Approach for Tracking Antimicrobial Stewardship Metrics
title_sort 1824. care transformation in infectious diseases: using a novel approach for tracking antimicrobial stewardship metrics
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252896/
http://dx.doi.org/10.1093/ofid/ofy210.1480
work_keys_str_mv AT minorsarah 1824caretransformationininfectiousdiseasesusinganovelapproachfortrackingantimicrobialstewardshipmetrics
AT burnsjordan 1824caretransformationininfectiousdiseasesusinganovelapproachfortrackingantimicrobialstewardshipmetrics
AT herreravictor 1824caretransformationininfectiousdiseasesusinganovelapproachfortrackingantimicrobialstewardshipmetrics